Form 4: BIO-TECHNE CEO Receives Stock Grant
Insider Transaction (Form 4)
Kim Kelderman, Chief Executive Officer and a Director of BIO-TECHNE Corp, reported multiple transactions in common stock on August 17, 2026.
Summary
- Grant/award: acquired 57,590 Restricted Stock Units on August 17, 2026; holds 57,590 after (Direct).
- Grant/award: acquired 93,582 Restricted Stock Units on August 17, 2026; holds 93,582 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Kim Kelderman — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-17 | Grant/award | Restricted Stock Units | 57,590 | — | — | 57,590 |
| 2026-08-17 | Grant/award | Restricted Stock Units | 93,582 | — | — | 93,582 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-17 | Grant/award (57,590 shares) |
| 2026-08-17 | Grant/award (93,582 shares) |
Keywords
insider transaction, Form 4, TECH, BIO-TECHNE Corp, neutral, Kim Kelderman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.